Lenz Therapeutics earnings were -$126.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LENZ earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$31.9M, down 23.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LENZ reported annual earnings of -$82.1M, with 65% growth. The next LENZ earnings date is Nov 4, 2026.
What were Lenz Therapeutics's earnings last quarter?
On LENZ's earnings call on Aug 11, 2026, Lenz Therapeutics (NASDAQ: LENZ) reported Q2 2026 earnings per share (EPS) of -$1.02, up 92.45% year over year. Total LENZ earnings for the quarter were -$31.92 million. In the same quarter last year, Lenz Therapeutics's earnings per share (EPS) was -$0.53.
The next LENZ earnings call is Nov 4, 2026. Add LENZ to your watchlist to be reminded of Lenz Therapeutics's next earnings date.
Is Lenz Therapeutics profitable or losing money?
As of the last Lenz Therapeutics earnings report, Lenz Therapeutics is currently losing money. Lenz Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$126.00 million, a 140.47% increase year over year.
What was LENZ's earnings growth in the past year?
As of Lenz Therapeutics's earnings date in Aug 11, 2026, Lenz Therapeutics's earnings has grown year over year. LENZ earnings in the past year totalled -$126.00 million.
What are Lenz Therapeutics's earnings expectations?
The current EPS estimate for Lenz Therapeutics's earnings report in Nov 4, 2026 is -$1.01.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.